HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Malcolm Spicer

US Consumer Health Managing Editor

Washington, DC
Malcolm has expertly covered the OTC drug and nutritional supplement industries and markets since 2006. He provides authoritative and highly analytical insight into how and why the US Food and Drug Administration regulates OTC drugs, including homeopathics, and nutritional supplement manufacturing and marketing and also how companies competing in these industries can most efficiently and effectively comply with FDA regulations, the cornerstone for their success.

Latest From Malcolm Spicer

Dr. Teal’s Tucks In Some Melatonin Topical Sleep Claims After P&G Challenge, Keeps Others Awake

PDC Brands declines to provide support for nine challenged claims for Dr. Teal’s line of balms, lotions, oils, soaps, sprays and other topicals. It continues using those after halting use of 25 other similar claims challenged by P&G, marketer of melatonin-containing ZzzQuil.

Ad Complaints Dietary Supplements

NPA Complaint For Preemption Argues New York Swings Wildly With Age-Restricted Sales Law

New York law crosses so many federal regulations it would also affect Rx drug sales while allowing consumers to file complaints alleging businesses violate the law, NPA argues in complaint filed in federal court in New York City.

US State News Dietary Supplements

Will Constitution Stop New York's Diet Pill Sales Rule Despite State Age-Restricting DXM OTCs?

NPA argues in complaint that limiting purchases of weight loss and bodybuilding OTC drugs and supplements to consumers 18 and older preempted not only by FD&C Act regulations but also by Commerce Clause of the US Constitution.

US State News OTC Drugs

Pharmavite Sitting Out Trendy Spin-Off Dance

"Otsuka is very, very committed to nutraceuticals generally, and supplements specifically,” says Pharmavite CEO Jeff Boutelle.

M & A Women's Health

Research Bonafides, Detailing Gynecologists Included In Pharmavite's Third Women’s Health Line

“This acquisition, plus our existing women's health brands of Equelle and Uqora, positions us, the combined group, as the leader in women's health in nutraceuticals in the US,” says Pharmavite CEO Jeff Boutelle. Bonafide markets supplements for long-term, sustainable support for needs that compound with age, including hot flashes, vaginal dryness, vaginal microbiome and sexual satisfaction.

Women's Health M & A

Democrat, Republican Pioneer Women In US House Won’t Return After 2024 Elections

Granger’s exit means House Appropriations will have different chair no matter which party wins majority 2024 elections; Democrats will lose senior House Energy and Commerce Health Subcommittee member with Eshoo’s retirement.

Elections Politics
See All
UsernamePublicRestriction

Register